Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Russian imaging groups on the verge

The CEO of Russia’s biggest imaging group says the market is under severe pressure and the plummeting rouble has already caused bankruptcies. The Diagnostic Treatment Centre (DTC) serves 1.35 million patients a year and has 93 imaging centres. But a combination of intense competition and currency depreciation will cut dollar profits to a third of 2014 levels this year.

Falck gambles on Africa

Danish healthcare provider Falck is starting a primary care operation in Sub-Saharan Africa. The investment is backed by the World Bank's investment arm, IFC, and the Danish Investment Fund for Developing Countries, IFU, The total investment is $100m with the first clinic expected to open in the first half of 2016.

Narayana IPO gets away

After an eternity of delays, India’s healthcare operators are finally getting their IPOs off the ground. Last week the lab group, Dr Lal Pathlabs, saw its IPO 33 times oversubscribed. This week it was the turn of Narayana Hrudayalaya, the specialist cardiology chain run by Dr Devi Shetty. It has already raised US$27.6m from 15 cornerstone investors, at the upper-band price of INR 250 (US$3.7) a share.

Confinimmo spends €60m in Germany and the Netherlands

Belgian REIT Cofinimmo, which owns a portfolio worth over €3.3bn, has bought several medical offices in the Netherlands for €29.5m with yields ranging between 7% and 8.3%. Earlier this week, it also acquired the Kaiser Karl rehabilitation clinic in Bonn, Germany for €30m as well, to be rented to 800-bed German operator Eifelhöhen-Klinik AG under a 25-year double net lease, for an initial yield of 7.32%.

Interview: Rajat Goel, CEO and Co-Founder of Eye-Q Hospitals

The Indian eye-care chain, Eye-Q Hospitals, is expanding fast. In March, it secured US$10 million of investment from the IFC and existing backers Helion and Nexus Venture Partners. This will help to build 65 hospitals in India within the next five years. But Eye-Q is also targeting virgin territory such as smaller cities and the African market. We spoke to Goel about the challenges of India and why he’s decided to look abroad.

Meinian turns up the heat on iKang

Chinese healthcare outpatient clinic group Meinian Onehealth Healthcare has increased its offer to rival iKang, which aims to delist from NASDAQ, to US$23.50 per American Depositary Share (ADS). This comes two weeks after iKang adopted a poison pill in response to Meinian's original counter-bid to take the group private, giving the right to its shareholders to buy more shares if Meinian manages to acquire a stake.

Jeremy Hunt plans bigger role for pharmacies

Jeremy Hunt, Secretary of State for Health in the UK, plans to give pharmacies a much bigger role in care, say sources who say he plans to circumvent the Pharmaceutical Services Negotiating Committee, powerful body in which the large chains, such as Boots, are strongly represented.

Eurofins pulls share issue

Eurofins, the highflying food to environmental lab group which has been building a diagnositc lab business in France and the USA has just pulled a €373m share issue.

Unicare moves into rehab

Unicare, one of three largest Norwegian private operators, has moved into rehabilitation, buying Fram, a hospital near Oslo. Unicare CEO Tom Tidemann told Healthcare Europa that he plans to enter new areas of healthcare in Norway as the private sector expands.

Find Us